Navigation Links
Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science
Date:2/4/2009

ARMSTRONG, Iowa, Feb. 4 /PRNewswire-FirstCall/ -- Art's Way Manufacturing, Inc. (Nasdaq: ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc. - Buildings For Science - has launched a new web site - http://www.buildingsforscience.com/ The new site, reflective of the company's new brand image, is graphically enhanced, clean and more user-friendly.

Art's Way Scientific (http://www.buildingsforscience.com) is a leading supplier of custom-designed modular laboratories for biocontainment, animal science, public health, and biomedical & security requirements.

Dan Palmer, General Manager of Art's Way Scientific - Buildings For Science - said, "Many of our clients and prospective customers we have looking at our website are scientific researchers and academic facility managers who tend to be very internet savvy when it comes to finding the appropriate suppliers for their specific building needs. It was important for us to develop a website that showcases our product knowledge, current information and competitive edge. One very important element of the new web site is that it hosts an improved technical library, which includes case studies and references."

J. Ward McConnell, Jr., Executive Chairman of the Board, said, "The goal of Art's Way Scientifics' new web site is to provide a one-stop technology resource that will enhance information exchange, continue industry education, and initiate a running dialogue about advancements in modular laboratory technology, design and construction. We are committed to providing our customers with a simple site providing the latest information to help them make informed decisions."

About Art's Way Scientific, Inc. - Buildings for Science:

Art's Way Scientific, Inc. is a wholly owned subsidiary of Art's Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers' critical requirements.

About Art's Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers. After market service parts are also an important part of the Company's business. We have two wholly owned subsidiaries. Art's Way Vessels, Inc. manufactures pressurized tanks and vessels and Art's Way Scientific, Inc. manufactures modular animal confinement buildings and modular laboratories.

    For More Information, Contact:  Jim Drewitz, Investor Relations
                              830-669-2466 jim@jdcreativeoptions.com

Or visit the Company's website at www.artsway-mfg.com/

This news release includes "forward-looking statements" within the meaning of the federal securities laws. Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company's products, domestic and international economic conditions, the management of growth and other risks detailed from time to time in the Company's Securities and Exchange Commission filings. Actual results may differ markedly from management's expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.


'/>"/>
SOURCE Art?s Way Manufacturing, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
2. Scopus to Expand Arts & Humanities Coverage
3. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
4. Tips on how to build a better home for biological parts
5. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
6. Tips on how to build a better home for biological parts
7. Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
8. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
9. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
10. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):